The Molecular Basis of Eicosanoid Action

References

• Smith WL. The eicosanoids and their biochemical mechanisms of action. Biochem J. 1989; 259: 315–24
   PubMed Web of Science ®Google Scholar
• Meagher E, FitzGerald G A. Disordered eicosanoid formation in pregnancy induced hypertension. Circulation 1993; 88: 1324–33
   PubMed Web of Science ®Google Scholar
• Smith JB, Dangelmaier C, Mauco G. Quantitation of arachidonate released during the platelet phosphatidylinositol response to thrombin. Prostaglandins, Leukotreines & Lipoxins, J M Bailey. Plenum Press, New York and London 1985; 205–11
   Google Scholar
• Clarke JD, Kin L-L, Kriz RW, Ramesha CS, Sultzman LA, Lin AY, Milona N, Knopf J L. A novel arachidonic acid-selective cytosolic PLA2 contains a CA2+-dependent translocation domain with homology to PKC and GAP. Cell. 1991; 65: 1043–51
   PubMed Web of Science ®Google Scholar
• Sharp JD, White DL, Chiou G, Goodson T, Gamboa GC, McClure D, Burgett S, Hoskins J, Skatrud PL, Sportsman JR, Becker GW, Kang LH, Roberts EF, Kramer R M. Molecular cloning and expression of human CA²⁺-sensitive cytosolic phospholipase A₂
   Google Scholar
• Kramer RM, Hession C, Johansen B, Hayes G, McGray P, Pingchang CE, Tizard R, Blake P R. Structure and properties of a human nonpancreatic phospholipase A2. J Biol Chem. 1989; 264: 5768–75
   PubMed Web of Science ®Google Scholar
• Lin LL, Lin AY, DeWitt D L. Interleukin-1 alpha induces the accumulation of cytosolic phospholipase A2 and the release of prostaglandin E2 in human fibroblasts. J Biol Chem. 1992; 267: 23451–4
   PubMed Web of Science ®Google Scholar
• Lin LL, Wartmann M, Lin AY, Knopf JL, Seth A, David R J. cPLA2 is phosphorylated and activated by MAP kinase. Cell. 1993; 72: 269–78
   PubMed Web of Science ®Google Scholar
• Nakamura T, Lin L-L, Kharbanda S, Knopf J, Kufe D. Macrophage colony stimulating factor activates phosphatidylcholine hydrolysis by cytoplasmic phospholipase A2. EMBO. 1992; 11: 4917–33
   PubMed Web of Science ®Google Scholar
• Crowl RM, Stoller TJ, Conroy RR, Stoner C R. Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response. J Biol Chem. 1991; 266: 2647–51
   PubMed Web of Science ®Google Scholar
• Nakazato Y, Simonson MS, Herman WH, Konieczkowski M, Sedor J R. Interleukin-1 alpha stimulates prostaglandin biosynthesis in serum-activated mesangial cells by induction of a nonpancreatic (Type II) phospholipase A2. J Biol Chem. 1991; 266: 14119–27
   PubMed Web of Science ®Google Scholar
• Schalkwijk C, Pfeilschifter J, Marki F, van den Bosch H. Interleukin-1 beta and forskolin-induced synthesis and secretion of Group II phospholipase A2 and prostaglandin E2 in rat mesangial cells is prevented by transforming growth factor-beta. J Biol Chem. 1992; 267: 8846–51
   PubMed Web of Science ®Google Scholar
• Hollenbach PW, Zilli DL, Laster S M. Inhibitors of transcription and translation act synergistically with tumor necrosis factor to cause the activation of phospholipase A2. J Biol Chem. 1992; 267: 29–42
   Web of Science ®Google Scholar
• Clark MA, Ozgur LE, Conway TM, Dispoto J, Crooke ST, Bomalaski J S. Cloning of a phospholipase A2-activating protein. Proc Natl Acad Sci. 1991; 88: 5418–22
   PubMed Web of Science ®Google Scholar
• Morrow JD, Awad JA, Boss HJ, Blair IA, Roberts LJ., II. Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci. 1992; 89: 10721–5
   PubMed Web of Science ®Google Scholar
• Arita H, Hanasaki K, Nakano T, Oka S, Teraoka H, Matsumoto K. Novel proliferative effect of phospholipase A2 in Swiss 3T3 cells via specific binding site. J Biol Chem. 1991; 266: 19139–41
   PubMed Web of Science ®Google Scholar
• Hazen SL, Ford DA, Gross R W. Activation of a membrane-associated phospholipase A2 during rabbit myocardial ischemia which is highly selective for plasmalogen substrate. J Biol Chem. 1991; 266: 5629–33
   PubMed Web of Science ®Google Scholar
• Hazen SL, Hall CR, Ford DA, Gross R W. Isolation of a human myocardial cytosolic phospholipase A2 isoform. J Clin Invest. 1993; 191: 2513–22
   Google Scholar
• Ford DA, Hazen SL, Saffitz JE, Gross R W. The rapid and reversible activation of a calcium-independent plasmalogen-selective phospholipase A2 during myocardial ischemia. J Clin Invest. 1991; 88: 331–5
   PubMed Web of Science ®Google Scholar
• Hazen SL, Zupan LA, Weiss R H. Getman DP, Gross RW. Suicide inhibition of canine myocardial cytosolic calcium-independent phospholipase A2. J Biol Chem. 1991; 266: 7227–32
   PubMed Web of Science ®Google Scholar
• Thunnissen MMGM, Eiso AB, Kalk KH, Drenth J, Dijkstra B W., Kuipers OP, Dijkman R, de Haas GH, Verheij H M. X-ray structure of phospholipase A2 complexed with a substrate-derived inhibitor. Nature 1990; 347: 689–91
   PubMed Web of Science ®Google Scholar
• Scott DL, White SP, Browning JL, Rosa JJ, Gelb MH, Sigler P B. Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudate. Science 1991; 2: 1007–9
   Google Scholar
• Scott DL, White SP, Otwinowski Z, Yuan W, Gelb MH, Sigler P B. Interfacial catalysis: the mechanism of action of phospholipase A2. Science 1990; 250: 1541–6
   PubMed Web of Science ®Google Scholar
• Zupan LA, Steffens DL, Berry CA, Landt M, Gross R W. Cloning and expression of a human 14-3-3 protein mediating phospholipolysis. J Biol Chem. 1992; 267: 8707–10
   PubMed Web of Science ®Google Scholar
• Kulmacz RJ, Lands WEM. Stoichiometry and kinetics of the interaction of prostaglandin H synthase with anti-inflammatory agents. J Biol Chem. 1985; 260: 12572–8
   PubMed Web of Science ®Google Scholar
• Rollins TE, Smith W L. Subcellular localization of prostaglandin-forming cycloox-ygenase in Swiss mouse 3T3 fibroblasts by electron microscopic im-munocytochemistry. J Biol Chem. 1980; 255: 4872–5
   PubMed Web of Science ®Google Scholar
• Eling TE, Glasgow WC, Curtis JF, Hubbard WC, Handler J A. Studies on the reduction of endogenously generated prostaglandin G2 by prostaglandin H synthase. J Biol Chem. 1991; 266: 12348–55
   PubMed Web of Science ®Google Scholar
• DeWitt DL, Smith W L. Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence. Proc Natl Acad Sci. 1988; 85: 1412–6
   PubMed Web of Science ®Google Scholar
• Kulmacz R J. Topography of prostaglandin H synthase. J Biol Chem. 1989; 264: 14136–44
   PubMedGoogle Scholar
• DeWitt DL, El-Harith EA, Kraemer SA, Andrews MJ, Yao EF, Armstrong RL, Smith W L. The aspirin and heme-binding sites of ovine and murine prostaglandin endoperoxide synthases. J Biol Chem. 1990; 265: 5192–8
   PubMed Web of Science ®Google Scholar
• Chen YNP, Marnett L F. Heme prosthetic group required for acetylation of prostaglandin H synthase by aspirin. FASEB J. 1989; 3: 2294–7
   PubMed Web of Science ®Google Scholar
• Shimokawa T, Smith W. Prostaglandin endoperoxide synthase. J Biol Chem. 1992; 267: 12387–92
   PubMed Web of Science ®Google Scholar
• Merlie JP, Fagan D, Mudd J, Needleman P. Isolation and characterization of the complementary DNA for sheep seminal vesicle prostaglandin endoperoxide synthase (cyclooxygenase). J Biol Chem. 1988; 263: 3550–3
   PubMed Web of Science ®Google Scholar
• Yokoyama C, Tanabe T. Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme. Biochem Biophys Res Comm. 1989; 165: 888–94
   PubMed Web of Science ®Google Scholar
• Funk CD, Funk LB, Kennedy ME, Pong AS, FitzGerald G A. Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB J. 1991; 5: 2304–11
   PubMed Web of Science ®Google Scholar
• Rosen GD, Birkenmeier TM, Rax A, Holtzman M J. Identification of a cyclooxygenase-related gene and its potential role in prostaglandin formation. Biochem Biophys Res Comm. 1989; 3: 1358–65
   Google Scholar
• Xie W, Chipman JG, Robertson DL, Erikson RL, Simmons D L. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci. 1991; 88: 2692–6
   PubMed Web of Science ®Google Scholar
• Fletcher BS, Kujubu DA, Perrin DM, Herschman H R. Structure of the mitogen-inducible TIS10 gene and demonstration that the TISlO-encoded protein is a functional prostaglandin G/H synthase. J Biol Chem. 1992; 267: 4338–44
   PubMed Web of Science ®Google Scholar
• O'Bannion MK, Winn VD, Young DGA. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc Natl Acad Sci. 1992; 89: 4888–92
   PubMed Web of Science ®Google Scholar
• Maier JAM, Hla T, Maciag T. Cyclooxygenase is an intermediate-early gene induced by interkeukin-1 in human endothelial cells. J Biol Chem. 1990; 265: 10805–8
   PubMed Web of Science ®Google Scholar
• Hla T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci. 1992; 89: 7384–8
   PubMed Web of Science ®Google Scholar
• Masferrer JL, Zweifel BS, Seibert K, Needleman P. Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. J Clin Invest. 1990; 86: 1375–9
   PubMed Web of Science ®Google Scholar
• Lee SH, Soyoola E, Chanmugam P, Hont S, Sun W, Zhong H, Liou S, Simmons D, Hwang D. Selective expression of mitogeninducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem. 1992; 267: 25934–38
   PubMed Web of Science ®Google Scholar
• Kujubu DA, Herschman H R. Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene. J Biol Chem. 1992; 267: 7991–4
   PubMed Web of Science ®Google Scholar
• Han J-W, Sadowski H, Young DA, Macara I G. Persistent induction of cyclooxygenase in pp60 v-src-transformed 3T3 fibroblasts. Proc Natl Acad Sci. 1990; 87: 3373–7
   PubMed Web of Science ®Google Scholar
• Tahara KT, Grollman EF, Saji M, Kohn L. Regulation of prostaglandin synthesis by thyrotropin, insulin or insulin-like growth factor-I and serum in FRTL-5 rat thyroid cells. J Biol Chem. 1991; 266: 440–8
   PubMed Web of Science ®Google Scholar
• Sirois J, Richards J S. Purification and characterisation of a novel, distinct isoform of prostaglandin endoperoxide synthase induced by human chorionic gonadotropin in granulosa cells of rat preovulatory follicles. J Biol Chem. 1992; 267: 6382–8
   PubMed Web of Science ®Google Scholar
• Sirois J, Simmons DL, Richards J S. Hormonal regulation of messenger ribonucleic acid encoding a novel isoform of prostaglandin endoperoxide H synthase in rat preovulatory follicles. J Biol Chem. 1992; 267: 11586–92
   PubMed Web of Science ®Google Scholar
• Rettori V, Gimeno MF, Karara A, Gonzalez MC, McCann S M. Interleukin 1 alpha inhibits prostaglandin E2 release to suppress pulsatile relase of luteinizing hormone but not follicle-stimulating hormone. Proc Natl Acad Sci. 1991; 88: 2763–7
   PubMed Web of Science ®Google Scholar
• Keirse MJNC, Erwich JJHM, Klok G. Not prostacyclin synthase but prostaglandin endoperoxide synthase increases with human placental development. Prostaglandins. 1986; 31: 527–34
   PubMedGoogle Scholar
• Eggleston DL, Wilken C, Van Kirk EA, Slaughter RG, Ji TH, Murdoch W J. Progesterone induces expression of endometrial messenger RNA encoding for cyclooxygenase (sheep). Prostaglandins. 1990; 39: 675–83
   PubMedGoogle Scholar
• Ishar M, Pasmanik M, Marcus S, Shemesh M. Dexamethasone inhibition of cyclooxygenase expression in bovine term placenta. Prostaglandins. 1992; 43: 239–54
   PubMed Web of Science ®Google Scholar
• Ishihara O, Khan H, Sullivan MHF, Elder M G. Interleukin-1 alpha stimulates decidual stromal cell cyclooxygenase enzyme and prostaglandin production. Prostaglandins 1992; 44: 43–52
   PubMedGoogle Scholar
• Lecomte M, Lecocq R, Dumont JE, Boeynaems J.-M. Covalent binding of arachidonic acid metabolites to human platelet proteins. J Biol Chem. 1990; 265: 5178–87
   PubMed Web of Science ®Google Scholar
• Distel RJ, Robinson GS, Spiegelman B M. Fatty acid regulation of gene expression. J Biol Chem. 1992; 267: 5937–41
   PubMedGoogle Scholar
• Green K, Christensen N, Bygdeman M. The chemistry and pharmacology of prostaglandins, with reference to human reproduction. J Reprod Fert. 1981; 62: 269–81
   PubMedGoogle Scholar
• Noort WA, de Zwart FA, Keirse MJNC. Increase in urinary thromboxane excretion during pregnancy and labor. Prostaglandins. 1987; 34: 413–21
   PubMedGoogle Scholar
• Makarainen L, Ylikorkala O. Amniotic fluid 6-keto-prostglandin F,a, and thromboxane B2 during labor. Am J Obstet Gynecol. 1984; 150: 765–8
   PubMed Web of Science ®Google Scholar
• Fitzgerald DJ, Entmann SS, Mulloy K, FitzGerald G A. Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension. Circulation 1987; 75: 956–63
   PubMed Web of Science ®Google Scholar
• Fitzgerald DJ, Wieslaw R, Murray R, Mayo G, FitzGerald G A. Thromboxane A2 synthesis in pregnancy-induced hypertension. Lancet. 1990; 335: 751–754
   PubMed Web of Science ®Google Scholar
• Parazzini F, Benodetto C, Frusco T, Gregorini G, Bocciolone L, Marozio L, Rumnero M, et al. Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension. Lancet. 1993; 341: 396–400
   PubMed Web of Science ®Google Scholar
• Wallenburg HCS, Dekker GA, Makovitz JW, Rotmans P. Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet. 1986; i: 1–3
   Google Scholar
• Beaufils M, Uzan S, Donsimoni R, Colau J C. Prevention of pre-eclampsia by early antiplatelet therapy. Lancet. 1985; i: 840–2
   Web of Science ®Google Scholar
• Benigni A, Gregorini G, Frusca T, et al. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk of pregnancy-induced hypertension. N Engl J Med. 1989; 321: 357–62
   PubMed Web of Science ®Google Scholar
• Schiff E, Pelig E, Goldberg M, et al. The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N Engl J Med. 1989; 321: 351–6
   PubMed Web of Science ®Google Scholar
• Hirata M, Hayashi Y, Ushikubi F, Yokota Y, Kageyama R, Nakanishi S, Narumiya S. Cloning and expression of cDNA for a human thromboxane A2 receptor. Nature 1991; 349: 617–20
   PubMed Web of Science ®Google Scholar
• Murray R, FitzGerald G A. Regulation of thromboxane receptor activation in human platelets. Proc Natl Acad Sci. 1989; 86: 124–128
   PubMed Web of Science ®Google Scholar
• Takahara K, Murray R, FitzGerald GA, Fitzgerald D J. The response to thromboxane A2 in human platelets: discrimination of two binding sites linked to distinct effector systems. J Biol Chem. 1990; 265: 6836–44
   PubMed Web of Science ®Google Scholar
• Brass LF, Sheller CC, Belmonte E J. Inositol 1,3,5-triphosphate-induced granule secretion in platelets. J Clin Invest. 1987; 79: 1269–75
   PubMed Web of Science ®Google Scholar
• Shenkert A, Goldsmith P, Unson CG, Spiegel A M. The G protein coupled to the thromboxane A2 receptor in human platelets is a member of the novel Gq family. J Biol Chem. 1991; 266: 9309–13
   PubMedGoogle Scholar
• Offermans S, Laugwitz K-L, Spicher K, Schultz G. G proteins of the G12-family are activated via thromboxane A2 and thrombin receptors in human platelets. Proc Natl Acad Sci USA 1993, (in press)
   Web of Science ®Google Scholar
• Takahashi K, Nammour TM, Fukunaga M, Ebert J, Morrow J, Roberts LJ, II, Hoover RL, Badr KF. Glomerular actions of a free radical-generated novel prostaglandin 8-epi-prostaglandin F2 alpha in the rat. J Clin Invest. 1992; 90: 136–41
   PubMed Web of Science ®Google Scholar
• Morrow JD, Minton TA, Roberts LJ., II. The F2-isoprostane, 8-epi-prostaglandin F2α, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist. Prostaglandins. 1992; 44: 155–63
   PubMedGoogle Scholar
• Ogeltree ML, Harris DN, Schumacher WA, Webb ML, Misra R N. Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/pro-staglandin endoperoxide receptor antagonist. J. Pharm Exper Therap. 1993; 264: 1–9
   PubMed Web of Science ®Google Scholar
• Fukunaga M, Makita N, Roberts LS, II, Marrow JD, Takahashi K, Badr K F. Evidence for the existence of F2 isoprostane receptors in rat vascular smooth muscle cells. An J Phys. 1993, (in press)
   Google Scholar
• Funk CD, Furci L, FitzGerald GA, Grygorczyk R, Rochette C, Bayne MA, Abramovitz M, Adam M, Metters K M. Cloning and expression of a cDNA for the human prostaglandin E receptor EP1, subtype. J Biol Chem 1993, (in press)
   Google Scholar
• Honda A, Sugimoto Y, Namba T, Watbe A, Irie A, Negishi M, Narumiya S, Ichikawa A. Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype. J Biol Chem 1993; 266: 7759–62
   Google Scholar
• Negishi M, Sugimoto Y., Irie A., Narumiya S, Ichikawa A. Two isoforms of prostaglandin E receptor EP3 subtype. J Biol Chem 1993; 268: 9517–21
   PubMed Web of Science ®Google Scholar
• Namba T, Sugimoto Y, Negishi M, Irie A, Ushikubi F, Kakizuka A, Ito S, Ichikawa A, Narumiya S. Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature 1993; 365: 166–70
   PubMed Web of Science ®Google Scholar
• Abramovitz M, Boei Y, Nguyen T, Rushmore TH, Bayne MA, Metters KM, Slipetz DM, Grygorczyk R. Cloning and expression of a cDNA for the human prostanoid FP receptor. J Biol Chem 1993, (in press)
   PubMedGoogle Scholar
• Sawai T, Negishi M, Nishigaki N, Ohno T, Ichikawa A. Enhancement of protein kinase C of prostacyclin receptor-mediated activation of adenylate cyclase through a calmodulin/myristoylated alanin-rich C kinase substrate (MARCKS) system in IC2 mast cells. J Biol Chem. 1993; 268: 1995–2000
   PubMed Web of Science ®Google Scholar
• Murray R, Shipp L, FitzGerald G A. Prostaglandin endoperoxide/thromboxane A2 receptor desensitization. Cross talk with adenylate cyclase in human platelets. J Biol Chem. 1990; 265: 21670–5
   PubMed Web of Science ®Google Scholar
• Foulon I, Bachir D, Galacteros F, Maclouf J. Increased in vivo production of thromboxane in patients with sickle cell disease is accompanied by an impairment of platelet functions to the thromboxane A2 agonist U46619. Arteriosclerosis Thrombosis 1993; 13: 421–6
   PubMedGoogle Scholar
• Jeremy JY, Mikhailidis DP, Dandona P. Thromboxane A2 analogue (U-46619) stimulates vascular PGl2 synthesis. Eur J Pharm. 1985; 107: 259–62
   PubMed Web of Science ®Google Scholar
• FitzGerald GA, Smith B, Pedersen AK, Brash A R. Increased prostacyclin biosynthesis is increased in patients with severe atherosclerosis and platelet activation. N Engl J Med. 1984; 310: 1065–8
   PubMed Web of Science ®Google Scholar
• Tang W-J, Gilman A G. Type specific regulation of adenylyl cyclase by G protein beta gamma subunits. Science 1991; 254: 1500–3
   PubMed Web of Science ®Google Scholar
• Funk CD, Furci L, Moran N, FitzGerald G A. A point mutation in the seventh hydropholic domain of the human thromboxan receptor allows discrimination between agonist and antagonist binding sites. Mol Pharm. 1993, (in press)
   Google Scholar
• Sessa WC, Nasjletti A. Dexamethasone selectively attenuates prostanoid-induced vasoconstrictor responses in vitro. Circ Res. 1990; 66: 383–8
   PubMed Web of Science ®Google Scholar
• Sessa WC, Halushka PV, Okwu A, Nasjletti A. Characterization of the vascular thromboxane A2/prostaglandin endoperoxide receptor in rabbit aorta. Circ Res. 1990; 67: 1562–9
   PubMed Web of Science ®Google Scholar
• Sano H, Hla T, Maier JAM, Crofford LJ, Case JP, Maciag T, Wilder R L. In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. J Clin Invest. 1992; 89: 97–108
   PubMed Web of Science ®Google Scholar
• Funk C, FitzGerald G A. Eicosanoid forming enzyme mRNA in human tissue: analysis on quantitative PCR. J Biol Chem. 1991; 266: 12508–13
   PubMed Web of Science ®Google Scholar